LOS ANGELES--(BUSINESS WIRE)--Kythera Biopharmaceuticals, Inc. (“Kythera”) announced today the appointment of Deepak Chadha, MS, MBA, RAC as Vice President, Regulatory Affairs. Chadha will lead Kythera’s regulatory submissions and oversee regulatory projects covering Kythera’s expansive product pipeline.
